1 / 30

Health Care Sector

Health Care Sector. Sang Mook Lee, Shinichiro Kido Bus-Fin 824 March 6, 2007. Health Care Sector - SIM holdings -. Industries of our Current Holdings : Pharmaceuticals HealthCare Equipment/Supplies Biotechnology Health Care Providers/Services

tyra
Télécharger la présentation

Health Care Sector

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Health Care Sector Sang Mook Lee, Shinichiro Kido Bus-Fin 824 March 6, 2007

  2. Health Care Sector - SIM holdings - Industries of our Current Holdings: Pharmaceuticals HealthCare Equipment/Supplies Biotechnology Health Care Providers/Services All of the above industries make up the majority of the Healthcare Sector Our current holdings are well diversified within our sector

  3. Market & Sector Overview • Total Healthcare market cap is approximately $2.3 trillion • Healthcare as a percentage of S&P500 • 12.15% • Third largest weighting in S&P500 • Behind Financials and Information Technology

  4. Health Care Sector Performance • 52 Week (-) • S&P 500: +13.50% • Health Care Sector: +7.85% • YTD (-) in 2006 • S&P 500: 13.62% • Health Care Sector: 5.78% • YTD and QTD (+) in 2007 • S&P 500: 2.24% • Health Care Sector: 3.37%

  5. Business Analysis • Defensive and relatively Matured • Performs independently of economic cycles and business factors • Beta for HealthCare Sector overall is 0.6 • External Factors • Aging Population, government regulation & trend towards consumer-oriented product • Risks • Earnings vulnerable to liability lawsuits, patent expirations, and development cost rising faster than sales

  6. SIM Current Holdings

  7. Recommendation • Sell all the shares of SYK 374bp  0bp • Buy MDT to 300bp 0bp  300bp • Increase TEVA by 74bp to 427bp 353bp  427bp

  8. Stryker Corporation Recommendation: SELL

  9. Stryker Corporation • Healthcare Equipment and Supplies Industry • Market Cap. 24.9 billion (S&P rating A), Revenue growth 15.7%, Net Income 23.8% at CAGR for 5 year. • Sales by line of business

  10. Stryker Stock Trend

  11. Stryker DCF

  12. Stryker Valuation

  13. Stryker Valuation

  14. Stryker Recommendation • Current Price $60.89 • Target Price – DCF valuation is lower than Current Price. (Almost limit for upward, now is the time for realizing capital gain) • Sell 374 bp to 0 bp.

  15. Medtronic Inc.MDT Recommendation: BUY

  16. MDT Corporation • Healthcare Equipment and Supplies Industry • Market Cap. 56.5 Billion (largest in the industry, S&P rating; AA-), Revenue growth 15.3%, Net Income 19.5% at CAGR for 5 year. • Sales by business segment

  17. MDT Stock Trend

  18. MDT Valuation

  19. MDT Valuation

  20. MDT DCF

  21. MDT Recommendation • Current price is $49.10 (on March 5, 2007) • Target price; • Buy to 300bp

  22. TEVA PharmaceuticalsTEVA Recommendation: BUY

  23. TEVA Pharmaceuticals • Drug Manufacturer – Generic (one of the largest makers and original drug) • Develops, manufactures, and markets generic and human pharmaceuticals, and active pharmaceutical ingredients, as well as animal health pharmaceutical products • Stock is an ADR • Sales by business segment

  24. TEVA Stock Trend

  25. TEVA Valuation

  26. TEVA Valuation

  27. TEVA DCF

  28. TEVA Recommendation • Currently price is $34.73 (on March 5, 2007) • Target price • Increase 74bp to 427bp

  29. Conclusion • Sell all the shares of SYK 374bp  0bp • Buy MDT to 300bp 0pb  300bp • Increase TEVA by 74bp to 427bp 353bp  427bp

  30. SIM Holdings after transaction

More Related